• purified CcSBPII using an IMAC-aEX protocol with reduced metal contamination and affinity tag removal, validated with ICP-MS, MALDI-ToF and CD • developed a multiplexed fluorescence assay to characterize binding affinity profile of CcSBPII • CcSBPII binds to Ni 2+ at low micromolar affinity, which is strengthened by an order of magnitude in the presence of L-histidine
Introduction
Clostridium carboxydivorans P7T is a Gram-positive anaerobic isolate from an agricultural settling lagoon (Stillwater, Oklahoma, USA) and is among a number of clostridium species that scientists and engineers have exploited for solventogenesis and biofuel production. [1] [2] [3] Underlying this biotechnology is acetogenesis, an anaerobic process where CO2 is shuttled into the Wood-Ljungdahl pathway to form acetyl-CoA ( Figure 1A) . 4 This process is catalyzed by enzymes that have metal co-factor requirements. For example, CO dehydrogenase (CODH) and acetyl-CoA synthase (ACS) possess iron-sulfur clusters that are (A) The ana operon is comprised of two sets of coding sequences. The first encodes an ABC transporter, which includes two solute binding proteins (SBP I and SBP II), two permease units (Permease I and Permease II), two nucleotide-binding domains (NBD I and NBD II), and an energy-coupling factor S-component. The second encodes acetogenesis-related enzymes, which includes two methyltransferases (MeTR I and MeTR II), one C-FeSP, and a cobalamin riboswitch after the transcriptional terminator (TT). A promoter (right angle arrow) and ribosome binding sites (white semi-circles) indicate where the operon and coding sequences start, respectively. Numbers below coding sequence names are identifiers that can be prefixed with "Ccar_" to locate them in the C. carboxidivorans genome (NZ_CP011803.1). SBP II (CcSBPII) is the protein of interest in this study. Sigma, #05419) for the internal standard. CcSBPII samples for metal analysis were prepared in the same manner with a final CcSBPII concentration of 0.67 μM (total volume = 3 mL per CcSBPII sample). For metal analysis, the ICP-MS (Thermo-Fisher X-Series 2) was equilibrated at 20 °C for 30 min. The system was then flushed with 2% TraceMetal TM Grade HNO3 for 30 min and tuned using the tune A solution (Fisher Scientific, #NC9063415). Triplicates were acquired and processed automatically by PlasmaLab, then visualized using GraphPad Prism 5.0.
Circular dichroism (CD)
The JASCO-800 spectropolarimeter was flushed with nitrogen gas (20 L/min) for 15 min and allowed to equilibrate at 25 °C with running distilled water before turning the lamp on. A 1-mm quartz cuvette (Millipore Sigma, #Z800015) was washed with MilliQ water, 70% EtOH, 70% HNO3, and a final wash with MilliQ water. 1 µM of purified CcSBPII in MilliQ water was added to the cuvette and analyzed in triplicate using the Measurement Mode between 180 -260 nm at a 1 nm interval. The curve was then smoothed using a Savitzky-Golay filter on CAPITO 31 , then visualized using GraphPad Prism 5.0.
Intrinsic protein fluorescence quenching -ligand titration assay (IPFQ-LTA)
IPFQ experiments for excitation and emission spectra of 0.25 μM bovine serum albumin (Millipore Sigma, #P0834) and 0.25 μM CcSPII were performed in a 10-mm quartz cuvette (Hellma, #104-10-40) on the SpectraMax M2 spectrophotometer (Molecular Devices). IPFQ-LTAs were performed in black, opaque 96-well microplates (Greiner Bio-One, #655076) using the same spectrophotometer with the following settings: top-read, 25 °C, λex 280 nm, λem 380 nm, PMT high, sensitivity 30, carriage speed high, 5 s shaking before endpoint reads, and shaking in between reads during kinetic reads. For all IPFQ-LTA tests, CcSBPII was combined with activity buffer (10 mM HEPES, pH 7.2) to 0.25 μM CcSBPII (200 μL total in a well) and allowed to equilibrate in the spectrophotometer for 20 min with shaking. Unless otherwise specified, ligands were prepared to 1 mM in activity buffer. After equilibration, aliquots of the ligands are added in stepwise fashion using a multichannel pipette up to a maximum of 100-120 μL. Each aliquot addition was followed by a 3 min equilibration with shaking before endpoint reads were made. IPFQ-LTAs were done in triplicate in addition to a negative control triplicate where CcSBPII was titrated with only activity buffer (no ligand).
In the IPFQ-LTA for non-specific binding of Ni 2+ to protein surfaces, 0.25 μM of CcSBPII, bovine serum albumin (Millipore Sigma, # A9418) and lysozyme (BioShop, #LYS702) were titrated with 1 mM NiSO4. In the promiscuity test, reagents of at least 97% purity were used to make ligand solutions for NiSO4, CoCl2, CuCl2, ZnCl2, MnCl2, and CdCl2. In the chelator and L-histidine test, complexes were made according to their stoichiometry. For example, Ni-(His)2 would require a 1:2 stoichiometric ratio between Ni 2+ and histidine (i.e. 1 mM Ni 2+ and 2 mM histidine to make 1 mM Ni-(His)2. In this fashion, 1 μM solutions were made for L-histidine (herein termed His), Ni-(His)2, Co-(His)2, Cu-(His)2; 20 μM solutions for His, Co-(His)2 and Cu-(His)2; and 1 mM solutions for Ni2-(Citrate)2, Ni-EDTA, Ni-DETA, citrate (2 mM), EDTA, and DETA (Millipore Sigma, # D93856).
In the pH and salinity test, the activity buffer was modified to have pH values of 2.5, 6.8, 7.2, 8.5 (adjusted with HCl and NaOH); and 0.01 M, 0.1 M, 1M NaCl or KCl. The buffer for the ligand, NiSO4 in these cases, remained at 10 mM HEPES, but the pH or salt concentrations were modified to match the cognate activity buffer (e.g. 10 mM HEPES, 0.1 M KCl, pH 7.2 activity buffer is titrated with 1 mM NiSO4, 10 mM HEPES, 0.1 M KCl, pH 7.2). Raw data was processed by first averaging the relative fluorescence units (RFU, arbitrary units, a.u.) for a set of IPQF-LTA replicates (either ligand test or negative control) at each titration step (stage 1). The averaged negative control data was then subtracted from the averaged ligand test data at each titration step to normalize the data (stage 2). Finally, the data was blanked by subtracting the RFU value just before the first titration step from the RFU values of the subsequent titration steps (stage 3). Standard deviation is calculated for stage 1 data, and error propagation is applied to stage 2 data to account for the subtraction of two means. The data was then fitted using a 1:1 binding model (Equation 1,2) in a non-linear regression solver (Excel) and visualized using GraphPad Prism 5.0.
Results & Discussion

CcSBPII expression, purification, and validation
CcSBPI and CcSBPII were discovered while creating a library of CjNikZ homologs through a Blastp search using the CjNikZ open-reading frame as a query. CcSBPII was selected for this study because it was readily solubilized first. CcSBPII was found to share 37% sequence identity to CjNikZ. CcSBPII's function was first investigated with homology modelling to predict its structure on SWISS-MODEL 29 using unliganded CjNikZ (PDB ID: 4OET) as the template (Figure 2A ). The modelling result of CcSBPII received a GMQE score 32 of 0.75 and a QMEAN 33 score of -2.75 indicating good reliability in the predicted structure. The crystal structure of liganded CjNikZ (PDB ID: 4OEV) reveals binding residues H43, H497 and H498 directly interacting with Ni 2+ , and R361 interacting with an oxalate molecule that helps coordinate the remaining octahedral geometry of Ni 2+ (different numbering due to the removal of the signal peptide in Lebrette et al. 2014 ). 18 CcSBPII possesses the same binding residues with the exception of K62 from the CjNikZ (green residues) and CcSBPII (cyan residues). (B) A multiple sequence alignment reveals CcSBPII uses K62 instead of H43 from CjNikZ, but has conserved binding residues otherwise (black arrows). Figure 3 . Similarities between CjNikZ and SBP II revealed by structural and sequence analysis. (A) A superimposition was made on PyMOL using the unliganded CjNikZ structure (tan, PDB ID: 4OET) and the predicted SBP II structure (red -Western lobe, blue -Eastern lobe, orange -hinge region) using SWISS-MODEL with 4OET as the template. Top-right panel and bottom-left panel are zoom-ins of the superimposition and highlight residue similarities and differences between CjNikZ (green residues) and SBP II (cyan residues). (B) A multiple sequence alignment reveals SBP II uses K62 instead of H43 from CjNikZ, but has conserved binding residues otherwise (black arrows). variable loop replacing the H43 from CjNikZ ( Figure  2B ). We speculate this substitution (His to Lys) may contribute to differences in the binding affinity profile between CcSBPII and CjNikZ.
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We were interested in developing a highthroughput detection method for metal-binding activity, so we wanted to complement this with a scalable recombinant protein purification method. Presently, metal affinity chromatography is the most efficient protocol for recombinant protein purification, which often does not require additional purification steps. 34 In our work, we chose to use an NTA resin workflow for immobilized metal-affinity chromatography, but anticipated contamination by metals and nontarget metal-binding proteins due to the nature of this method. Therefore, several precautions were taken during CcSBPII's purification to remove these contaminants. First, CcSBPII was expressed in large scale cultures using the E. coli expression strain LOBSTR with genetically modified copies of arnA and slyD resulting in a higher purity of purified target proteins. 35 Second, CcSBPII's ability to bind to NTA resins charged with cobalt and copper was tested to determine if using a Ni-NTA resin could be avoided, thus minimizing the introduction of nickel to CcSBPII ( Figure 3A ). We found that Co-NTA had comparable performance to Ni-NTA based on the size of the bands produced on the SDS-PAGE analysis, so we proceeded to use Co-NTA for all further purifications.
Overall, CcSBPII was purified to approximately 98% purity (Table 1 ) through a combination of purification techniques ( Figure 3B ). Following Co-NTA purification, a 72-hr dialysis step was performed where TEV protease was added to cleave the 6xHisTag from CcSBPII, and Chelex 100 was added to the dialysis buffer to remove excess nickel in the solution. MALDI-ToF was used to confirm the completeness of TEV cleavage ( Figure  4A ). Based on the open-reading frame, CcSBPII is expected to have a molecular weight of 57,269 Da, but 59,694 Da with the inclusion of the 6xHisTag and TEV cleavage site. The observed molecular weights were 55'539 Da and 57'893 Da, respectively, which are approximately 1750 Da lower than the theoretical values. This discrepancy is explained by which part of the peak one decides to use for analysis. One could use the centre of the peaks, which would align better with the theoretical molecular weights in this case. For CcSBPII, the maximum peak of each spectrum was used instead, revealing a difference of 2'354 Da. 8
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The theoretical molecular weight of the 6xHisTag and TEV cleavage site is 2'385 Da, indicating successful removal of this affinity tag from CcSBPII. Previous studies have used EDTA to remove metal contaminants from the target protein samples, but EcNikA and its homologues have been observed to bind to Ni-EDTA, which we wanted to avoid if this is true for CcSBPII. 14, 17, 18 ICP-MS was used to evaluate the effectiveness of Chelex 100 at removing nickel from the CcSBPII sample inside the dialysis bag ( Figure 4B ). After the 72-hr dialysis, we found that it provided a 40% reduction in nickel from 8.6 ppb to 5.3 ppb when CcSBPII was present, and a 43% reduction in nickel from 2.1 ppb to 1.2 ppb when CcSBPII was not present. The dialyzed and cleaved CcSBPII sample to remove heavy metals from the Co-IMAC protein eluent, which is collected after applying the cell lysate to the Co-NTA and washing the resin with washing buffer. This protein eluent is combined with TEV for cleavage and dialyzed for 72 hrs with and without Chelex 100, labelled "+TEV +Chelex" and "+TEV +Chelex", respectively. A negative control is included where the cell lysate volume is replaced with binding buffer to determine the extent of cobalt released from the resin during Co-IMAC without the presence of proteins. No TEV is added to the eluent in this case and is dialyzed in the same fashion, labelled "no protein + Chelex" and "no protein -Chelex". CcSBPII after the final 24 hr dialysis, prior to freezing, was also evaluated by ICP-MS and labelled "Post-aEX". (C) CD spectrum of CcSBPII after being blanked with 10 mM HEPES, pH 7.2.
was then passed through a Co-NTA resin twice to remove uncut CcSBPII and any remaining contaminant proteins. Finally, the flow-through was applied to an FPLC with an anion exchange resin (MonoQ) to improve the protein purity and dialyzed once more with Chelex 100 for 24 hr to reduce the concentration of NaCl and any remaining metals. This whole procedure yielded CcSBPII at 2.2 mg/L of culture with a final concentration of 1 mg/mL with 0.5 ppb nickel, representing a 0.01 metal-protein ratio that is recommended by Handing et al. 2018 and used in a study that measured metal binding affinity by ITC. 18, 36 Prior to using CcSBPII in IPFQ-LTAs after thawing, the integrity of its secondary structures was evaluated using CD ( Figure 4C ). We found that it maintained a primarily α-helical conformation, but a peak was missing at 220 nm that is typical of α-helical proteins. This is likely explained by CcSBPII's antiparallel β-pleated sheets found in the core of the Western and Eastern lobes, which can produce a different spectrum that could reduce the steepness of the peaks around 220 nm and 200 nm (Figure 2A) . Consequently, the observed CD spectrum for CcSBPII is likely a product of both the α-helices and β-pleated sheet spectra, suggesting that its secondary structures are preserved throughout the purification workflow and after thawing. One batch of purified CcSBPII was used for both the development of the IPFQ-LTA, and characterization of its binding affinity profile with the optimized IPFQ-LTA.
Developing the IPFQ-LTA in 96-well microplate format IPQF-LTAs in microplate format have been performed for inhibition studies with organic molecules 37, 38 , but to our knowledge it has not been well-described for Ni-BPs. There are two prerequisites for IPFQ-LTAs to provide accurate information about a protein's binding parameters: 1) the protein should have tryptophan residues, ideally near the binding sites and 2) the ligand to be titrated should have minimal absorption of light at the λex and λem used in fluorescence reads. CcSBPII contains seven tryptophan residues, two of which (W404 & W419) are located adjacent to the binding site and the other five evenly dispersed across the Western and Eastern lobes ( Supplementary Figure 1) . We first used fluorescence excitation and emission spectra to compare CcSBPII and BSA's behavior in a quartz cuvette format and a 96-well black opaque microplate format chosen to minimize cross-well interference ( Figure  5A ). CcSBPII and BSA excite most strongly near 280 nm in both formats. CcSBPII and BSA emitted most strongly at 370 nm in cuvette format, but 380 nm in microplate format, so λex 280 nm and λem 380 nm were used in subsequent fluorescence reads. Notably, the cuvette format produced less resolved spectra than the microplate format for both CcSBPII and BSA, which may reflect its susceptibility to noise.
Initial IPFQ-LTA trials in microplate format did not yield binding curves likely due to protein adsorption to the well and therefore poor homogeneity that resulted in large RFU fluctuations during fluorescence reads. To address this, we tested various shaking regimes and equilibration times (data not shown) and found that CcSBPII needed constant shaking for at least 5 min for the signal to stabilize before an IPFQ-LTA. Overall, the best regime was a 15-20 min "pre-equilibration" period before an IPFQ-LTA, and 3 min equilibration period during an IPFQ-LTA, between each titration step ( Figure 5B ).
We also found that the initial signal to noise ratio was high, possibly due to minor differences in pipetting between replicates and intrinsic variability with the spectrophotometer, which caused standard deviations to be up to 50% of the signal (data not shown). We addressed this by testing different concentrations of CcSBPII in IPFQ-LTAs with Ni 2+ and found that 0.025 mg/mL (0.2 μM) of CcSBPII was enough to yield standard deviations that were approximately 10% of the signal ( Figure 5C ). The magnitude of the standard deviations did not change upon increasing the concentration of CcSBPII, suggesting that the variability does not arise from CcSBPII. To verify that changes in fluorescence throughout the IPFQ-LTAs arose from binding activity and not non-specific adsorption interactions between Ni 2+ and the outer surface of CcSBPII, 0.25 μM BSA and 0.25 μM lysozyme were also titrated with Ni 2+ (Figure 5D ). We found that neither yielded notable changes in fluorescence in the concentration range tested compared to CcSBPII, which clearly shows quenching of the fluorescence with increasing exposure to Ni 2+ . 
Inner-filter effect and binding model selection
Precautions were taken in this study to address some common pitfalls in IPFQ experiments, as discussed previously by others. 39, 40 Changes in protein fluorescence upon titration of a ligand can be a result of the inner filter effect (IFE) where the ligand absorbs light at the λex and λem used in the fluorescence reads. We analyzed the UV-Vis absorption spectra for the divalent metals and chelators used in this study, at the maximum concentrations used in the IPFQ-LTAs, by comparing theirs to the activity buffer's (10 mM HEPES, pH 7.2) UV-Vis spectrum. We found that none of the metals or chelators differed from the activity buffer (data not shown). We note that ferrous (Fe 2+ ) and ferric iron (Fe 3+ ) were also tested and showed very strong absorbance compared to the activity buffer, hence why they are not included in this study. Since we used ligand and ligand-chelator concentrations that were at least ten-fold higher than the protein concentration, we assumed the final concentration of the ligand (La) in the wells to be equal to the concentration of the ligand available (Lfree) for binding. From this, we used a 1:1 binding model (Equation 1) in a non-linear regression to determine Fmax and Kd values. 39, 40 For the L-histidine chelator test where the chelator and ligand-chelator concentrations were at points smaller than the CcSBPII concentration in the well, we modified the 1:1 binding model to included the Hill coefficient (Equation 2). Fp is the processed fluorescent reading (stage 3) that was observed. Fmax is the theoretical maximum change in fluorescence during ligand saturation, which describes the degree of quenching caused by the ligand binding to the protein. Kd is the dissociation constant, which describes the protein's affinity for a ligand. These parameters are summarized in Table 2 . * metals that were titrated were at 1 mM **His-chelated metals were titrated at 20 μM
Analysis of metal promiscuity
The promiscuity test ( Figure 6A,B) explored CcSBPII's ability to bind to divalent metal ions known to form complexes with proteins 41, 42 : Ni 2+ , Co 2+ , Cu 2+ , Zn 2+ , Cd 2+ , and Mn 2+ . We observed binding to Ni 2+ (Kd 32.6 µM), which is less than the reported value for CjNikZ with Ni 2+ (Kd 1.6 ± 0.2 µM). This difference may arise from the presence of lysine (K62) in the variable loop instead of the histidine that is in CjNikZ (Figure  2) . At pH 7.2, which was used in this test, lysine is protonated (pKa 10.79) so it does not participate in metal-binding. Rather, it destabilizes the protein-metal interaction through charge-charge forces. 43 We also found that CcSBPII binds to Co 2+ and Cu 2+ (Kd 142.6 µM and 12.2 µM, respectively), where Cu 2+ has an Fmax that is approximately four-fold larger than Ni 2+ . In the presence of Cu 2+ , the binding of CcSBPII to Ni 2+ is inhibited, showing evidence for competition between these two metals ( Supplementary Figure 2) . The other three metals tested did not yield interpretable binding curves. Cd 2+ is a much bulkier ion than the other first row transition metals and has a preference for sulfur donor groups and a tetrahedral geometry which CcSBPII does not provide. 42, 44 Zn 2+ and Mn 2+ could not saturate CcSBPII in the concentration range that was tested, suggesting they are not targets for the cognate ABC transporter. While Zn 2+ and Mn 2+ have similar radii to the other first row transition metals, Zn 2+ has a preference for a tetrahedral coordination geometry and Mn 2+ generally has weak affinity for proteins. 45, 46 Put together, CcSBPII's metal promiscuity reflects the Irving-William series that recapitulates determinants for protein-metal-binding affinity into the series Mn 2+ < Cd 2+ < Co 2+ < Ni 2+ < Cu 2+ > Zn 2+ . 46, 47 This promiscuity test reveals CcSBPII is selective for Co 2+ , Ni 2+ , and Cu 2+ in order of increasing affinity, which suggests the cognate ABC transporter is a copper-specific importer. However, our chelator tests suggest otherwise.
Analysis of chelator utilization
The chelator test ( Figure 6C ) explored CcSBPII's ability to bind to complexes of Ni 2+ with two organic chelators previously studied in Ni-BP binding assays: citrate and EDTA. Additionally, DETA is a flotation reagent used in hydrometallurgical processes and was also tested to gauge CcSBPII's ability to bind to environmental contaminants. We found that CcSBPII binds to all three complexes (Kd 28.0 µM, 218.7 µM, and 121 µM, respectively), whereas the control with titration of the chelator without the Ni 2+ produced no hyperbolic curves. Of note, CcSBPII's ability to bind to Ni 2+ chelated by EDTA and DETA raises questions about whether these chelators are also translocated through the permease dimer of the cognate ABC transporter and into the cytoplasm where they could be metabolized. L-histidine was also tested in the same concentration range used for these chelators, but saturation occurred almost immediately in the second titration step (data not shown), which lead us to probe whether CcSBPII was able to use this chelator to specifically bind to Ni 2+ , rather than Co 2+ and Cu 2+ , at a sub-micromolar range.
The L-histidine test (Figure 6D ,E) explored CcSBPII's ability to bind to complexes of Ni 2+ , Co 2+ , and Cu 2+ with L-histidine molecules (generally termed M-(His) where "M" is for the divalent metal ion). The M-(His) solutions are prepared before IPFQ-LTAs such that the molar stoichiometry is 1:2 between the metals and L-histidine, therefore making M-(His)2 complexes. This was to ensure all three metals could form their preferred octahedral coordination geometries. We first tested binding in the low nanomolar range and found CcSBPII was able to bind to Ni-(His)2 (Kd 0.19 µM) and not the other complexes or L-histidine alone. We then tested binding in the very low micromolar range and found CcSBPII was able to bind to Co-(His)2 and Cu-(His)2 (Kd 1.7 µM and 2.7 µM, respectively). The presence of L-histidine enhances CcSBPII's ability to bind to Ni 2+ , Co 2+ , and Cu 2+ by a factor of 171, 80, and 4, respectively. Moreover, CcSBPII binds to Ni-(His)2 and Co-(His)2 stronger than Cu-(His)2 by a factor of 14 and 1.6, respectively. This represents a reversal of the binding preference shown for bare Ni 2+ , Co 2+ , and Cu 2+ without chelators, which suggests CcSBPII overcomes Cu 2+ competition by using L-histidine in a similar fashion to intestinal pathogens that use siderophores and siderophore-like molecules to out-compete host defense systems. 48, 49 We postulate CcSBPII possesses a second coordination sphere that may be enhancing its ability to bind to Ni 2+ and Co 2+ by orienting its metal-binding residues to accommodate chelators like L-histidine.
A limitation of the IPFQ-LTA is its ability to precisely elucidate the mechanism of binding between the ligand and the protein. While CcSBPII exhibits a large change in fluorescence with nanomolar concentrations of Ni-(His)2, it is an assumption that it binds to Ni 2+ in complex with two molecules of Lhistidine. The structure of CjNikZ binding a single Ni 2+ and a single L-histidine molecule (PDB ID: 4OEU) contrasts with other structures like EcNikA (PDB ID: 4I8C) and YpYntA (PDB ID: 4OFL) that bind to a single Ni 2+ complexed with two L-histidine molecules. From just the L-histidine chelator test, it is unclear what exact complex CcSBPII is binding to. However, CcSBPII exhibited slightly sigmoidal binding curves for Ni-(His)2 and Co-(His)2 with Hill coefficients of 1.6 and 1.4, respectively and a relatively large Hill coefficient of 2.3 for Cu-(His)2. Analytical size exclusion chromatography with CcSBPII revealed these Hill coefficients do not arise from oligomerization of the protein (data not shown), likely indicating that there may be multiple binding events present when the concentration of the ligand and chelators are at least an order of magnitude less than the concentration of CcSBPII. These deviations from hyperbolic behavior may provide insight into the mechanism of binding. For example, it may be the case that CcSBPII can only bind to M-(His) or M-(His)2 complexes. It is known that Cu 2+ is in equilibrium with multiple complexes of Lhistidine other than Cu-(His) and Cu-(His)2, which decreases the availability of preferred complexes in solution that CcSBPII can readily bind. 50 This would be an issue at very low nanomolar concentrations of Ni 2+ and L-histidine where the concentration of CcSBPII is approximately two orders of magnitude larger. Overall, the chelator test reveals CcSBPII's promiscuity is not limited to bare divalent metal ions, but also chelators, which appears to be an advantage that allows it to use L-histidine to very specifically bind to Ni 2+ . In addition to what CcSBPII binds to, IPFQ-LTAs can reveal its optimum operational window.
Analysis of pH and salinity effects
The pH test ( Figure 6F ) explored CcSBPII's ability to bind to Ni 2+ at an acidic pH of 2.5 and circumneutral pH of 6.8, 7.2, and 8.2, chosen intentionally to avoid the isoelectric point of CcSBPII (pH 5.8) and the precipitation of nickel-hydroxides beginning at pH 8.5. We found that increasing alkalinity of the activity buffer decreased the Kd and increased the Fmax, meaning that stronger binding occurred with more alkaline conditions. This may be attributed to two phenomena. First CcSBPII's histidine residues (pKa 6.04) that participate in metal-binding are more likely to be deprotonated with increasing concentrations of hydroxides, leading to more charge transfer between the imidazole nitrogen to Ni 2+ . Additionally, the lysine residue (K62) of the variable loop can be deprotonated by approximately an order of magnitude, which may allow it to begin participating in metal-binding, though this may only be a small contribution. Second, CcSBPII likely requires hydroxides to complete the octahedral coordination geometry that Ni 2+ prefers, so the increased presence of hydroxides in more alkaline conditions could help.
The salinity test ( Figure 6G ,H) explored CcSBPII's ability to bind to Ni 2+ in the presence of NaCl and KCl. We found that increasing the concentration of both salts decreased Kd and Fmax, meaning that weaker binding occurred at molar level salt concentrations. However, CcSBPII binding to Ni 2+ in the presence of 0.01 M NaCl had a higher Fmax than the case without any salt present. We speculate a low concentration of NaCl allowed the surface of the CcSBPII protein to be stabilized by Na + . This would allow CcSBPII to adopt a more compact structure where tryptophan quenching by Ni 2+ was more effective, leading to greater changes in fluorescence as Ni 2+ was titrated. However, the general decrease in CcSBPII's ability to bind to Ni 2+ with increasing salinity is likely a consequence of an increase in ionic strength that causes the activity coefficients for Ni 2+ and CcSBPII to deviate from 1 (non-ideal conditions). This raises questions about how the activity buffer for IPFQ-LTAs and other techniques should be designed to characterize a protein's binding affinity profile: conditions that better match physiological conditions, or conditions that are as close to pure water as possible to capture a signal derived from only the protein of interest.
